CA2771232A1 - Purification of vwf for increased removal of non-lipid enveloped viruses - Google Patents

Purification of vwf for increased removal of non-lipid enveloped viruses Download PDF

Info

Publication number
CA2771232A1
CA2771232A1 CA2771232A CA2771232A CA2771232A1 CA 2771232 A1 CA2771232 A1 CA 2771232A1 CA 2771232 A CA2771232 A CA 2771232A CA 2771232 A CA2771232 A CA 2771232A CA 2771232 A1 CA2771232 A1 CA 2771232A1
Authority
CA
Canada
Prior art keywords
cation exchange
exchange resin
protein
vwf
wash buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA2771232A
Other languages
English (en)
French (fr)
Inventor
Artur Mitterer
Meinhard Hasslacher
Christa Mayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43063204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2771232(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of CA2771232A1 publication Critical patent/CA2771232A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2771232A 2009-08-20 2010-08-20 Purification of vwf for increased removal of non-lipid enveloped viruses Pending CA2771232A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23557009P 2009-08-20 2009-08-20
US61/235,570 2009-08-20
PCT/US2010/046180 WO2011022657A1 (en) 2009-08-20 2010-08-20 Purification of vwf for increased removal of non-lipid enveloped viruses

Publications (1)

Publication Number Publication Date
CA2771232A1 true CA2771232A1 (en) 2011-02-24

Family

ID=43063204

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2771232A Pending CA2771232A1 (en) 2009-08-20 2010-08-20 Purification of vwf for increased removal of non-lipid enveloped viruses

Country Status (18)

Country Link
US (1) US9315560B2 (enExample)
EP (1) EP2467399B2 (enExample)
JP (1) JP5838159B2 (enExample)
KR (1) KR101894600B1 (enExample)
CN (2) CN106008697B (enExample)
AU (1) AU2010284116B9 (enExample)
BR (1) BR112012003802B1 (enExample)
CA (1) CA2771232A1 (enExample)
DK (1) DK2467399T3 (enExample)
ES (1) ES2562256T5 (enExample)
HU (1) HUE026907T2 (enExample)
IN (1) IN2012DN01849A (enExample)
MX (1) MX2012002129A (enExample)
NZ (1) NZ598249A (enExample)
PL (1) PL2467399T3 (enExample)
PT (1) PT2467399E (enExample)
SG (2) SG10201408106WA (enExample)
WO (1) WO2011022657A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
KR101772674B1 (ko) 2008-10-21 2017-09-01 박스알타 인코퍼레이티드 동결건조된 재조합 vwf 제제
SG11201408490PA (en) * 2012-06-21 2015-01-29 Baxter Int Virus filtration of cell culture media
US9902942B2 (en) 2013-02-22 2018-02-27 Agency For Science, Technology And Research Chromatographic purification of virus preparations with negatively charged particles
DK3152230T3 (da) * 2014-06-06 2019-11-11 Octapharma Ag Præparat omfattende faktor viii og von willebrand-faktor-peptider
DK3158055T3 (da) 2014-06-13 2019-10-14 Csl Ltd Forbedret produktion af recombinant von willebrand-faktor i en bioreaktor
KR20250088663A (ko) 2017-08-23 2025-06-17 체에스엘 베링 게엠베하 폰 빌레브란트 인자의 바이러스 여과 방법
EP3768697A1 (en) 2018-03-21 2021-01-27 Baxalta Incorporated Separation of vwf and vwf propeptide by chromatographic methods
CA3244889A1 (en) 2022-03-08 2023-09-14 Equashield Medical Ltd FLUID TRANSFER STATION IN A ROBOTIC PHARMACEUTICAL PREPARATION SYSTEM

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941763A (en) * 1975-03-28 1976-03-02 American Home Products Corporation PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
EP0218692A4 (en) 1985-04-11 1988-03-22 Childrens Medical Center VON WILLEBRAND FACTOR.
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
AT406373B (de) * 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
AT405403B (de) * 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
US6531577B1 (en) 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
ES2261589T3 (es) * 1998-05-06 2006-11-16 Genentech, Inc. Composicion de anticuerpos anti-her2.
AU2005322067B8 (en) * 2004-12-27 2012-07-26 Takeda Pharmaceutical Company Limited Polymer-von Willebrand factor-conjugates

Also Published As

Publication number Publication date
DK2467399T3 (en) 2017-01-23
US20110092681A1 (en) 2011-04-21
CN106008697A (zh) 2016-10-12
BR112012003802A2 (pt) 2016-11-22
CN106008697B (zh) 2020-08-04
ES2562256T3 (es) 2016-03-03
AU2010284116B2 (en) 2015-02-12
BR112012003802B1 (pt) 2022-10-25
EP2467399B1 (en) 2015-11-11
NZ598249A (en) 2014-04-30
IN2012DN01849A (enExample) 2015-08-21
EP2467399B2 (en) 2023-02-01
SG178478A1 (en) 2012-04-27
AU2010284116B9 (en) 2015-03-26
PL2467399T3 (pl) 2016-05-31
JP2013502434A (ja) 2013-01-24
US9315560B2 (en) 2016-04-19
KR101894600B1 (ko) 2018-09-03
ES2562256T5 (es) 2023-07-20
HUE026907T2 (en) 2016-07-28
WO2011022657A1 (en) 2011-02-24
MX2012002129A (es) 2012-06-08
PT2467399E (pt) 2016-03-18
CN102482341A (zh) 2012-05-30
EP2467399A1 (en) 2012-06-27
JP5838159B2 (ja) 2015-12-24
AU2010284116A1 (en) 2012-03-08
KR20120065342A (ko) 2012-06-20
SG10201408106WA (en) 2015-01-29

Similar Documents

Publication Publication Date Title
AU2010284116B9 (en) Purification of VWF for increased removal of non-lipid enveloped viruses
KR101804136B1 (ko) 응고 인자 viii을 정제하는 방법
AU2010319425B2 (en) Von Willebrand factor (vWF)-containing preparations, and methods, kits, and uses related thereto
JP7458980B2 (ja) アルキルグリコシドによるタンパク質精製およびウイルス不活化
KR20040111351A (ko) 단백질 제제의 안정화
EP2125866A1 (en) Method for the purification of recombinant blood coagulation factor ix enriched in sulfated and/or phosphorylated molecules
KR101842412B1 (ko) 형질전환 인자 ⅶ 의 정제 방법
US6034222A (en) Method for the separation of recombinant pro-factor IX from recombinant factor IX
US8058411B2 (en) Method for producing mature VWF from VWF pro-peptide
CN112533940A (zh) 通过色谱方法分离vwf和vwf前肽
AU2015201483A1 (en) Purification of VWF for Increased Removal of Non-Lipid Enveloped Viruses
HK1230206A1 (en) Purification of vwf for increased removal of non-lipid enveloped viruses
HK1170744A (en) Purification of vwf for increased removal of non-lipid enveloped viruses
HK1230206B (zh) 纯化vwf以增加非-脂质包封的病毒的去除
HK40050722A (en) Separation of vwf and vwf propeptide by chromatographic methods
HK1144577B (en) Method for producing mature vwf from vwf pro-peptide
HK1170244B (en) Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150807

EEER Examination request

Effective date: 20150807

EEER Examination request

Effective date: 20150807

EEER Examination request

Effective date: 20150807

EEER Examination request

Effective date: 20150807

EEER Examination request

Effective date: 20150807